Insider Activity of Rottinghaus Scott T.
According to the SEC Form 4 filings, Rottinghaus Scott T., being in a position of
- Chief Medical Officer at Enanta Pharmaceuticals, Inc.,оver the last 12 months, has bought 0 shares, and sold 798 shares for $11,356,over all time since 2023-12-05, has bought 0 shares, and sold 14143 shares for $214,225.
Biography of Rottinghaus Scott T.
No biography is available at this moment.